Bone Biologics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | |||
EBITDA | -748 | -1,038 | -2,458 | 60 |
EBIT | -748 | -2,076 | -1,554 | -891 |
Net Income | -740 | -1,017 | -1,522 | -941 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -458 | -926 | -1,353 | -572 |
Cash | 6,640 | 2,746 | 3,325 | 3,566 |
Basic Shares | 557 | 3,183 | 2,954 | 1,753 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | 0 | 0 | |
EBITDA | -4,112 | 479 | -4,397 | -803 |
EBIT | -8,331 | -8,948 | -8,062 | -1,101 |
Net Income | -4,112 | -8,949 | -1,485 | -1,610 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,124 | -9,555 | -3,566 | -1,228 |
Cash | 3,325 | 3,026 | 7,538 | 6,675 |
Basic Shares | 1,517 | 263 | 47 | 43 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.33 |
2025-03-31 | -$0.31 |
2024-12-31 | -$2.88 |
2024-09-30 | -$14.22 |
